The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review.

[1]  I. Mathauer,et al.  Subsidized health insurance coverage of people in the informal sector and vulnerable population groups: trends in institutional design in Asia , 2016, International Journal for Equity in Health.

[2]  E. Teijlingen,et al.  Diabetes prevention and management in South Asia: a call for action , 2016 .

[3]  D. Prabhakaran,et al.  Cardiovascular Diseases in India: Current Epidemiology and Future Directions , 2016, Circulation.

[4]  Harshal R. Patil,et al.  Lifestyle Choices Fuel Epidemics of Diabetes and Cardiovascular Disease Among Asian Indians. , 2016, Progress in cardiovascular diseases.

[5]  U. Colón-Ramos,et al.  Moving Toward Universal Health Coverage (UHC) to Achieve Inclusive and Sustainable Health Development: Three Essential Strategies Drawn From Asian Experience Comment on "Improving the World's Health Through the Post-2015 Development Agenda: Perspectives from Rwanda". , 2015, International journal of health policy and management.

[6]  D. Watkins,et al.  Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review , 2015, BMC Public Health.

[7]  Marc Suhrcke,et al.  The Economic Costs of Type 2 Diabetes: A Global Systematic Review , 2015, PharmacoEconomics.

[8]  Md. Nazrul Islam Mondal,et al.  Awareness, Treatment, and Control of Diabetes in Bangladesh: A Nationwide Population-Based Study , 2015, PloS one.

[9]  P. Gogate,et al.  Economic Burden of Diabetes in Urban Indians , 2014, The open ophthalmology journal.

[10]  A. Ferrario,et al.  The economic burden of diabetes in India: a review of the literature , 2014, Globalization and Health.

[11]  Atta Abbas,et al.  DIRECT COST OF TREATMENT OF DIABETES MELLITUS TYPE 2 IN PAKISTAN , 2014 .

[12]  Mohammed K. Ali,et al.  Non-communicable diseases in South Asia: contemporary perspectives. , 2014, British medical bulletin.

[13]  Longjiang Li,et al.  Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. , 2014, The Cochrane database of systematic reviews.

[14]  B. Monz,et al.  Treatment Costs of Stroke Related to Nonvalvular Atrial Fibrillation Patients in India-A Multicenter Observational Study. , 2014, Value in health regional issues.

[15]  M. Engelgau,et al.  The household‐level economic burden of heart disease in India , 2014, Tropical medicine & international health : TM & IH.

[16]  K. Satyavani,et al.  Direct costs associated with chronic kidney disease among type 2 diabetic patients in India , 2014, Indian journal of nephrology.

[17]  M. Hendriks,et al.  Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology , 2014, Global health action.

[18]  U. Linnenkamp,et al.  Global estimates of diabetes prevalence for 2013 and projections for 2035. , 2014, Diabetes research and clinical practice.

[19]  Jaymie A Henry,et al.  Value innovation: an important aspect of global surgical care , 2014, Globalization and Health.

[20]  J. Pandian,et al.  Cost of stroke from a tertiary center in northwest India. , 2013, Neurology India.

[21]  U. Mateti,et al.  Health-care cost of diabetes in South India: A cost of illness study , 2013, Journal of research in pharmacy practice.

[22]  N. Shrestha,et al.  Cost of diabetes mellitus care among patients attending selected outpatient clinics. , 2013, JNMA; journal of the Nepal Medical Association.

[23]  A. Moran,et al.  Cardiovascular disease prevention in South Asia: gathering the evidence. , 2013, Global heart.

[24]  Akanksha Srivastava,et al.  Age and Sex Pattern of Cardiovascular Mortality, Hospitalisation and Associated Cost in India , 2013, PloS one.

[25]  A. Staines,et al.  Cost Comparisons and Methodological Heterogeneity in Cost-of-illness Studies: The Example of Colorectal Cancer , 2013, Medical care.

[26]  M. Drummond,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[27]  V. Viswanathan,et al.  The costs of treating long-term diabetic complications in a developing country: a study from India. , 2013, The Journal of the Association of Physicians of India.

[28]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[29]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[30]  B. Vellas,et al.  Methodological considerations in cost of illness studies on Alzheimer disease , 2012, Health Economics Review.

[31]  J. Moss,et al.  Cost-of-Illness Studies , 2011, PharmacoEconomics.

[32]  A. Murphy,et al.  Socio-economic inequalities in the financing of cardiovascular & diabetes inpatient treatment in India , 2011, The Indian journal of medical research.

[33]  V. Viswanathan,et al.  The socioeconomics of diabetes from a developing country: a population based cost of illness study. , 2010, Diabetes research and clinical practice.

[34]  S. Adiga.  HEALTH CARE COST INCURRED BY PATIENTS OF DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL SETTING IN COASTAL KARNATAKA DISTRICT , 2010 .

[35]  J. Salomon,et al.  Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis , 2010, PLoS medicine.

[36]  V. Viswanathan,et al.  Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India. , 2009, Diabetes research and clinical practice.

[37]  Ayman Fareed,et al.  The personal cost of diabetic foot disease in the developing world—a study from Pakistan , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[38]  J. Nagpal,et al.  Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey. , 2008, The Journal of the Association of Physicians of India.

[39]  J. D. de Jong,et al.  The Dutch health insurance reform: switching between insurers, a comparison between the general population and the chronically ill and disabled , 2008, BMC health services research.

[40]  Taghreed Adam,et al.  The burden and costs of chronic diseases in low-income and middle-income countries , 2007, The Lancet.

[41]  David Parkin,et al.  Economic Analysis in Health Care , 2007 .

[42]  Anil Kapur,et al.  Economic analysis of diabetes care. , 2007, The Indian journal of medical research.

[43]  Ambady Ramachandran,et al.  Increasing Expenditure on Health Care Incurred by Diabetic Subjects in a Developing Country , 2007, Diabetes Care.

[44]  S. Yusuf,et al.  The burden of cardiovascular disease in the Indian subcontinent. , 2006, The Indian journal of medical research.

[45]  H. D. de Vet,et al.  Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria , 2005, International Journal of Technology Assessment in Health Care.

[46]  M. Wasay,et al.  Cost of acute stroke care at a tertiary care hospital in Karachi, Pakistan. , 2003, JPMA. The Journal of the Pakistan Medical Association.

[47]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[48]  Sanjay Jain,et al.  Pattern of use and pharmacoeconomic impact of antihypertensive drugs in a north Indian referral hospital , 2001, European Journal of Clinical Pharmacology.

[49]  A. Sood,et al.  Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic. , 2001, Indian heart journal.

[50]  V. Bhargava,et al.  A study of drug utilisation and cost of treatment in patients hospitalised with unstable angina , 2000, European Journal of Clinical Pharmacology.

[51]  Ambady Ramachandran,et al.  Cost burden to diabetic patients with foot complications--a study from southern India. , 2000, The Journal of the Association of Physicians of India.

[52]  Ambady Ramachandran,et al.  Expenditure on health care incurred by diabetic subjects in a developing country--a study from southern India. , 2000, Diabetes research and clinical practice.

[53]  T O Jefferson,et al.  Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.

[54]  Sowjanya,et al.  Cost Analysis of Drugs Used In Elderly Patients with Cardiovascular Disorder. , 2015 .

[55]  C. Mullins,et al.  Cost-of-Illness Studies , 2012, PharmacoEconomics.

[56]  James Thomas,et al.  A web-based tool for adjusting costs to a specific target currency and price year , 2010 .

[57]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.